Presentation and outcome of paediatric membranous non-proliferative lupus nephritis

Pediatric Nephrology

Volumn 30, Issue 1, 2015, Pages 113-121

  Hugle, Boris ^a,c   Silverman, Earl D ^a   Tyrrell, Pascal N ^a,b   Harvey, Elizabeth A ^a   Hébert, Diane ^a   Benseler, Susanne M ^a,d,e  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c German Centre for Pediatric and Adolescent Rheumatology   (Germany)

^d HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^e UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Children; Class V nephritis; Membranous glomerulonephritis; Outcome; Systemic lupus erythematosus; Treatment

Indexed keywords

ADOLESCENT; CHILD; COHORT ANALYSIS; FEMALE; HUMAN; LUPUS NEPHRITIS; MALE; PATHOPHYSIOLOGY; REMISSION; TREATMENT OUTCOME;

ADOLESCENT; CHILD; COHORT STUDIES; FEMALE; HUMANS; LUPUS NEPHRITIS; MALE; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 84937511385     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-014-2908-2     Document Type: Article

References (32)

1. Hiraki LT, Benseler SM, Tyrrell PN, Hebert D, Harvey E, Silverman ED (2008) Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study. J Pediatr 152:550–556
2. Bogdanovic R, Nikolic V, Pasic S, Dimitrijevic J, Lipkovska-Markovic J, Eric-Marinkovic J, Ognjanovic M, Minic A, Stajic N (2004) Lupus nephritis in childhood: a review of 53 patients followed at a single center. Pediatr Nephrol 19:36–44
3. Hagelberg S, Lee Y, Bargman J, Mah G, Schneider R, Laskin C, Eddy A, Gladman D, Urowitz M, Hebert D, Silverman E (2002) Longterm followup of childhood lupus nephritis. J Rheumatol 29:2635–2642
4. Austin HA, Illei GG (2005) Membranous lupus nephritis. Lupus 14:65–71
5. Yang LY, Chen WP, Lin CY (1994) Lupus nephritis in children—a review of 167 patients. Pediatrics 94:335–340
6. Weening JJ, D’Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T, Ferrario F, Fogo AB, Ginzler EM, Hebert L, Hill G, Hill P, Jennette JC, Kong NC, Lesavre P, Lockshin M, Looi LM, Makino H, Moura LA, Nagata M (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 65:521–530
7. Gruppo Italiano per lo Studio della Nefrite Lupica (GISNEL) (1992) Lupus nephritis: prognostic factors and probability of maintaining life-supporting renal function 10 years after the diagnosis. Am J Kidney Dis 19:473–479
8. Donadio JV Jr (1977) Treatment of lupus nephritis. Nephron 19:186–189
9. Pasquali S, Banfi G, Zucchelli A, Moroni G, Ponticelli C, Zucchelli P (1993) Lupus membranous nephropathy: long-term outcome. Clin Nephrol 39:175–182
10. Huong DL, Papo T, Beaufils H, Wechsler B, Bletry O, Baumelou A, Godeau P, Piette JC (1999) Renal involvement in systemic lupus erythematosus. A study of 180 patients from a single center. Medicine (Baltimore) 78:148–166
11. Sloan RP, Schwartz MM, Korbet SM, Borok RZ (1996) Long-term outcome in systemic lupus erythematosus membranous glomerulonephritis. Lupus nephritis collaborative study group. J Am Soc Nephrol 7:299–305
12. Cramer CH 2nd, Mills M, Valentini RP, Smoyer WE, Haftel H, Brophy PD (2007) Clinical presentation and outcome in a cohort of paediatric patients with membranous lupus nephritis. Nephrol Dial Transplant 22:3495–3500
13. Nathanson S, Salomon R, Ranchin B, Macher MA, Lavocat MP, Krier MJ, Baudouin V, Azema C, Bader-Meunier B, Deschenes G (2006) Prognosis of lupus membranous nephropathy in children. Pediatr Nephrol 21:1113–1116
14. Wong SN, Chan WK, Hui J, Chim S, Lee TL, Lee KP, Leung LC, Tse NK, Yuen SF (2009) Membranous lupus nephritis in Chinese children–a case series and review of the literature. Pediatr Nephrol 24:1989–1996
15. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114:555–576
16. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35:630–640
17. Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, Bacon P, Bombardieri S, Hanly J, Hay E, Isenberg D, Jones J, Kalunian K, Maddison P, Nived O, Petri M, Richter M, Sanchez-Guerrero J, Snaith M, Sturfelt G, Symmons D, Zoma A (1996) The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 39:363–369
18. Gladman DD, Ibanez D, Urowitz MB (2002) Systemic lupus erythematosus disease activity index 2000. J Rheumatol 29:288–291
19. Liang MH, Schur PH, Fortin P, St. Clair EW, Balow JE, Costenbader K, Crofford L, Pablo P d, Dooley MA, Finckh A, Gordon CP, Lundberg IE, Meyrier A, Nived O, Ponticelli C, Schneider MK, Singh A, Wallace DJ (2006) The American college of rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials. Arthritis Rheum 54:421–432.
20. Linder BL, Esteban NV, Yergey AL, Winterer JC, Loriaux DL, Cassorla F (1990) Cortisol production rate in childhood and adolescence. J Pediatr 117:892–896
21. Ardoin S, Birmingham DJ, Hebert PL, Yu CY, Rovin BH, Hebert LA (2011) An approach to validating criteria for proteinuric flare in systemic lupus erythematosus glomerulonephritis. Arthritis Rheum 63:2031–2037
22. Houssiau FA, D’Cruz D, Sangle S, Remy P, Vasconcelos C, Petrovic R, Fiehn C, de Ramon GE, Gilboe IM, Tektonidou M, Blockmans D, Ravelingien I, le Guern V, Depresseux G, Guillevin L, Cervera R (2010) Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the maintain nephritis trial. Ann Rheum Dis 69:2083–2089
23. Mercadal L, Montcel ST, Nochy D, Queffeulou G, Piette JC, Isnard-Bagnis C, Martinez F (2002) Factors affecting outcome and prognosis in membranous lupus nephropathy. Nephrol Dial Transplant 17:1771–1778
24. Baqi N, Moazami S, Singh A, Ahmad H, Balachandra S, Tejani A (1996) Lupus nephritis in children: a longitudinal study of prognostic factors and therapy. J Am Soc Nephrol 7:924–929
25. Chan TM, Li FK, Hao WK, Chan KW, Lui SL, Tang S, Lai KN (1999) Treatment of membranous lupus nephritis with nephrotic syndrome by sequential immunosuppression. Lupus 8:545–551
26. Hahn BH, McMahon MA, Wilkinson A, Wallace WD, Daikh DI, Fitzgerald JD, Karpouzas GA, Merrill JT, Wallace DJ, Yazdany J, Ramsey-Goldman R, Singh K, Khalighi M, Choi SI, Gogia M, Kafaja S, Kamgar M, Lau C, Martin WJ, Parikh S, Peng J, Rastogi A, Chen W, Grossman JM (2012) American college of rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res 64:797–808
27. Mina R, von Scheven E, Ardoin SP, Eberhard BA, Punaro M, Ilowite N, Hsu J, Klein-Gitelman M, Moorthy LN, Muscal E, Radhakrishna SM, Wagner-Weiner L, Adams M, Blier P, Buckley L, Chalom E, Chedeville G, Eichenfield A, Fish N, Henrickson M, Hersh AO, Hollister R, Jones O, Jung L, Levy D, Lopez-Benitez J, McCurdy D, Miettunen PM, Quintero-del Rio AI, Rothman D, Rullo O, Ruth N, Schanberg LE, Silverman E, Singer NG, Soep J, Syed R, Vogler LB, Yalcindag A, Yildirim-Toruner C, Wallace CA, Brunner HI (2012) Consensus treatment plans for induction therapy of newly diagnosed proliferative lupus nephritis in juvenile systemic lupus erythematosus. Arthritis Care Res 64:375–383
28. Appel GB, Cohen DJ, Pirani CL, Meltzer JI, Estes D (1987) Long-term follow-up of patients with lupus nephritis. A study based on the classification of the World Health Organization. Am J Med 83:877–885
29. Radhakrishnan J, Moutzouris DA, Ginzler EM, Solomons N, Siempos II, Appel GB (2010) Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis. Kidney Int 77:152–160
30. Thamer M, Hernan MA, Zhang Y, Cotter D, Petri M (2009) Prednisone, lupus activity, and permanent organ damage. J Rheumatol 36:560–564
31. Kasitanon N, Fine DM, Haas M, Magder LS, Petri M (2006) Hydroxychloroquine use predicts complete renal remission within 12 months among patients treated with mycophenolate mofetil therapy for membranous lupus nephritis. Lupus 15:366–370
32. Austin HA 3rd, Illei GG, Braun MJ, Balow JE (2009) Randomized, controlled trial of prednisone, cyclophosphamide, and cyclosporine in lupus membranous nephropathy. J Am Soc Nephrol 20:901–911